Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 330

1.

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease.

Caslake R, Macleod A, Ives N, Stowe R, Counsell C.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006661. doi: 10.1002/14651858.CD006661.pub2. Review.

PMID:
19821381
2.

Monoamine oxidase B inhibitors for early Parkinson's disease.

Macleod AD, Counsell CE, Ives N, Stowe R.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004898. Review.

PMID:
16034956
3.

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.

Stowe R, Ives N, Clarke CE, Deane K; van Hilten, Wheatley K, Gray R, Handley K, Furmston A.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007166. doi: 10.1002/14651858.CD007166.pub2. Review.

PMID:
20614454
4.

Ropinirole for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2000;(3):CD001516. Review. Update in: Cochrane Database Syst Rev. 2001;(1):CD001516.

PMID:
10908503
5.

Ropinirole for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001516. Review.

PMID:
11279718
6.

Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.

Deane KH, Spieker S, Clarke CE.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004553. Review.

PMID:
15495118
7.

Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KD.

Cochrane Database Syst Rev. 2001;(1):CD001519. Review.

PMID:
11279721
8.

Cabergoline for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001518. Review.

PMID:
11279720
9.

Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001517. Review.

PMID:
11279719
10.

Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2000;(3):CD001517. Review. Update in: Cochrane Database Syst Rev. 2001;(1):CD001517.

PMID:
10908504
11.
12.

Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Clarke C E, Speller J M, Clarke J A.

Cochrane Database Syst Rev. 2000;(3):CD002259. Review.

PMID:
10908539
13.

Bromocriptine versus levodopa in early Parkinson's disease.

Ramaker C, van Hilten JJ.

Cochrane Database Syst Rev. 2000;(3):CD002258. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD002258.

PMID:
10908538
14.

Recent developments in the pharmacological treatment of Parkinson's disease.

Tuite P, Riss J.

Expert Opin Investig Drugs. 2003 Aug;12(8):1335-52. Review.

PMID:
12882620
15.

Dopamine agonist therapy in early Parkinson's disease.

Stowe RL, Ives NJ, Clarke C, van Hilten J, Ferreira J, Hawker RJ, Shah L, Wheatley K, Gray R.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006564. doi: 10.1002/14651858.CD006564.pub2. Review.

PMID:
18425954
16.

Bromocriptine versus levodopa in early Parkinson's disease.

van Hilten JJ, Ramaker CC, Stowe R, Ives NJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD002258. Review.

PMID:
17943771
17.

Pramipexole for levodopa-induced complications in Parkinson's disease.

Clarke C E, Speller J M, Clarke J A.

Cochrane Database Syst Rev. 2000;(3):CD002261. Review.

PMID:
10908540
18.

Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.

van Hilten JJ, Ramaker CC, Stowe R, Ives NJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003634. Review.

PMID:
17943795
19.

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.

PD Med Collaborative Group, Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE.

Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Erratum in: Lancet. 2014 Sep 27;384(9949):1186.

PMID:
24928805
20.

Dopamine agonists for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006009. doi: 10.1002/14651858.CD006009.pub2. Review.

PMID:
21412893

Supplemental Content

Support Center